Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

Consolidated Statements of Cash Flows

v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Cash flow provided by (used in) Operating activities    
Net loss for the year $ (64,120) $ (70,792)
Adjustments for    
Amortization of deferred revenue (118) (118)
Amortization of property and equipment 20 22
Amortization of acquired intellectual property and other intangible assets 1,545 1,434
Change in value and amortization of short term investments discount (premium) (note 18) 13 67
Revaluation of contingent consideration 236 502
Loss on disposal of equipment 0 1
Change in estimated fair value of derivative warrant liabilities 9,954 23,924
Stock-based compensation 6,860 4,242
Adjustments to reconcile profit (loss) (45,610) (40,718)
Contingent consideration milestones paid 0 (2,150)
Net change in other operating assets and liabilities (note 18) (6,000) 1,699
Net cash used in operating activities (51,610) (41,169)
Investing activities (note 18)    
Purchase of short term investments (36,084) (97,996)
Proceeds on disposal/maturity of short term investments 36,093 90,018
Purchase of equipment (30) (25)
Capitalized patent costs (45) 0
Net cash used in investing activities (66) (8,003)
Proceeds from exercise of warrants    
Net proceeds from issuance of common shares 0 162,324
Proceeds from exercise of derivative warrants 0 8,684
Proceeds from exercise of warrants 3,071 232
Proceeds from exercise of stock options 943 3,912
Net cash generated from financing activities 4,014 175,152
(Decrease) Increase in cash and cash equivalents during the year (47,662) 125,980
Cash and cash equivalents – Beginning of year 165,629 39,649
Cash and cash equivalents – End of year $ 117,967 $ 165,629